未登录 Health-related quality of life in patients with newly diagnosed advanced ovarian cancer receiving maintenance olaparib plus bevacizumab (PAOLA-1/ENGOT-ov25) 新诊断晚期卵巢癌患者接受奥拉帕尼联合贝伐珠单抗维持治疗(PAOLA-1/ENGOT-ov25)的健康相关生活质量 Florence Joly, MD, PhD; Amélie Anota, PhD; Sylvie Chabaud, MSc; Claire Cropet, MSc; Frank Priou, MD; Philipp Harter, MD, PhD; Sandro Pignata, MD, PhD; Isabel Palacio, MD; Edgar Petru, MD; Hiroaki Kobayashi, MD; Ignace Vergote, MD, PhD; Gabriella Parma, MD; Johanna Mäenpää, MD, PhD; Eric Raymond, MD; Beyhan Ataseven, MD; Carmela Pisano, MD; Nuria Lainez, MD; Irina Tsibulak, MD; Kan Yonemori, MD; Peter Vuylsteke, MD; Maria Teresa Lapresa, MD; Mansoor Raza Mirza, MD; Patrick Bouchaert, MD; Paul Buderath, MD; Domenica Lorusso, MD, PhD; Ana Herrero, MD; Lauriane Eberst, MD; Alexander Burges, MD; Giovanni Scambia, MD, PhD; Eugenia Ortega, MD; Cécile Guillemet, MD; Eric Pujade-Lauraine, MD, PhD; Jean-Emmanuel Kurtz, MD, PhD; Isabelle Ray-Coquard, MD, PhD; null 分享 收藏
分享 收藏
分享 收藏
HER2 and HER3 expression during neoadjuvant treatment of HER2-negative early breast cancer: potential for biomarker-driven sequencing of T-DXd and HER3-DXd HER2和HER3在HER2阴性早期乳腺癌新辅助治疗期间的表达:T-DXd和HER3-DXd生物标志物驱动的序贯治疗的潜力 Singer, Christian Fridolin; Jahn, Stephan Wenzel; Hlauschek, Dominik; Heber, Ulrike Maria; Mang-Manger, Charlotte; Egle, Daniel; Balic, Marija; Pichler, Angelika; Pfeiler, Georg; Kacerovsky-Strobl, Stephanie; Suppan, Christoph; Ritter, Magdalena; Petru, Edgar; Greil, Richard; Bago-Horvath, Zsuzsanna; Deutschmann, Christine; Steger, Guenther Georg; Seifert, Michael; Fitzal, Florian; Bartsch, Rupert; Santhanagopal, Anu; Machacek-Link, Jana; Sellami, Dalila; Schwarz, Magdalena; Fesl, Christian; Soelkner, Lidija; Esker, Stephen; Filipits, Martin; Gnant, Michael 分享 收藏
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed high-risk, locally advanced cervical cancer (ENGOT-cx11/ GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial Pembrolizumab或安慰剂联合放化疗,然后用pembrolizumab或安慰剂治疗新诊断的高危局部晚期宫颈癌 (ENGOT-cx11/ GOG-3047/KEYNOTE-A18): 一项随机,双盲,安慰剂对照的3期试验的总生存期结果 Lorusso, Domenica; Xiang, Yang; Hasegawa, Kosei; Scambia, Giovanni; Leiva, Manuel; Ramos-Elias, Pier; Acevedo, Alejandro; Cvek, Jakub; Randall, Leslie; Gomes, Andrea Juliana Pereira de Santana; Mejia, Fernando Contreras; Helpman, Limor; Akilli, Huseyin; Lee, Jung-Yun; Saevets, Valeriya; Zagouri, Flora; Gilbert, Lucy; Sehouli, Jalid; Tharavichitkul, Ekkasit; Lindemann, Kristina; Colombo, Nicoletta; Chang, Chih-Long; Bednarikova, Marketa; Zhu, Hong; Oaknin, Ana; Christiaens, Melissa; Petru, Edgar; Usami, Tomoka; Liu, Peng; Yamada, Karin; Toker, Sarper; Keefe, Stephen M.; Pignata, Sandro; Duska, Linda R. 分享 收藏
Pathological response according to early metabolic remission in an interim FDG-PET scan and to tumor infiltrating lymphocytes - A secondary analysis of the phase II trial ABCSG 52/ATHENE investigating atezolizumab in early HER2+BC Rinnerthaler, Gabriel; Egle, Daniel; Bartsch, Rupert; Schmitt, Clemens; Petzer, Andreas; Balic, Marija; Petru, Edgar; Denison, Ursula; Singer, Christian F.; Bjelic-Radisic, Vesna; Gampenrieder, Simon; Knauer, Michael; Sotlar, Karl; Brunner, Christine; Posch, Florian; Hlauschek, Dominik; Solkner, Lidija; Bago-Horvath, Zsuzsanna; Filipits, Martin; Gili, Manuela; Gnant, Michael; Greil, Richard 分享 收藏
Real-world outcomes with first-line ribociclib plus endocrine therapy in patients with metastatic HR+, HER2-breast cancer: Fourth interim analysis of REACH AUT trial Singer, Christian F.; Egle, Daniel; Greil, Richard; Petru, Edgar; Oehler, Leopold; Balic, Marija; Schoffmann, Laurenz; Pfeiler, Georg; Marhold, Maximilian; Brunner, Christine; Haider, Karin; Galid, Arik; Pluschnig, Ursula; Haslbauer, Ferdinand; Hubalek, Michael; Redl, Andreas; Flatschacher, Julia; Uthman, Shanow; Mraz, Bernhard; Bartsch, Rupert 分享 收藏
Single-agent metronomic versus weekly oral vinorelbine as first-line chemotherapy in patients with HR-positive/HER2-negative advanced breast cancer: The randomized Tempo Breast study Freyer, Gilles; Martinez-Janez, Noelia; Kukielka-Budny, Bozena; Ulanska, Malgorzata; Bourgeois, Hugues; Munoz, Montserrat; Morales, Serafin; Calero, Juan Bayo; Cortesi, Laura; Pinter, Tamas; Palacova, Marketa; Cherciu, Nelli; Petru, Edgar; Ettl, Johannes; de Almeida, Cecilia; Villanova, Gustavo; Raymond, Romain; Minh, Christine Ta Thanh; Rodrigues, Ana; Cazzaniga, Marina E. 分享 收藏
Phase III double-blind randomized placebo controlled trial of atezolizumab in combination with carboplatin and paclitaxel in women with advanced/recurrent endometrial carcinoma Colombo, N.; Harano, K.; Hudson, E.; Galli, F.; Antill, Y.; Choi, C. H.; Rabaglio, M.; Marme, F.; Petru, E.; Lai, C. H.; Biagioli, E.; Madrid, L. Farinas; Takehara, K.; Allan, K.; Lee, Y. C.; Piovano, E.; Zamagni, C.; Tasca, G.; Ferrero, A.; Ginesta, M. P. Barretina 分享 收藏
Identification of transcript adenosine fingerprint to enrich for A2AR and PD-1 inhibition responders Alt, Isabella; Sehlke, Robert; Lobley, Anna; Baumgaertler, Claudia; Stulic, Maja; Hackner, Klaus; Dzurillova, Lucia; Petru, Edgar; Hadjari, Laudia; Lafleur, Judith; Singer, Josef; Krall, Nikolaus; Sufliarsky, Jozef; Hefler, Lukas; Fureder, Thorsten; Taubert, Christina; Payne, Andrew; Boudesco, Christophe; Vladimer, Gregory Ian 分享 收藏
Discovering novel targetable pathways by combining functional and multi-omic data from primary ovarian cancer samples Gutierrez-Perez, Irene; Erguner, Bekir; Buphamalai, Pisanu; Van Ham, Joost; Heinz, Paul; Aranha, Valentin; Okumura, Rin; Waltenberger, Elisabeth; Alt, Isabella; Baumgaertler, Claudia; Stulic, Maja; Petru, Edgar; Minichsdorfer, Christoph; Lafleur, Judith; Hefler, Lukas; Hadjari, Laudia; Dzurillova, Lucia; Sufliarsky, Jozef; Krall, Nikolaus; Fureder, Thorsten; Vladimer, Gregory Ian; Vilagos, Bojan; Sehlke, Robert 分享 收藏
Assessing the impact of antiemetic guideline compliance on prevention of chemotherapy-induced nausea and vomiting: Results of the nausea/emesis registry in oncology (NERO)yy Aapro, Matti; Caprariu, Zoe; Chilingirov, Petio; Chrapava, Marika; Curca, Razvan-Ovidiu; Gales, Laurentia; Grigorescu, Alexandru C.; Huszno, Joanna; Karlinova, Bara; Kellnerova, Renata; Malejcikova, Miroslava; Marinca, Mihai; Petru, Edgar; Pluzanski, Adam; Pokorna, Petra; Pribulova, Zuzana; Rubach, Maryna; Steger, Gunther G.; Tesarova, Petra; Valekova, Lubica; Yordanov, Nicolay; Walaszkowska-Czyz, Anna 分享 收藏
Capecitabine in combination with bendamustine in pretreated women with HER2-negative metastatic breast cancer: results of a phase II trial (AGMT MBC-6) Rinnerthaler, Gabriel; Gampenrieder, Simon Peter; Petzer, Andreas; Hubalek, Michael; Petru, Edgar; Sandholzer, Margit; Andel, Johannes; Balic, Marija; Melchardt, Thomas; Hauser-Kronberger, Cornelia; Schmitt, Clemens A.; Ulmer, Hanno; Greil, Richard 分享 收藏
Conventional versus reverse sequence of neoadjuvant epirubicin/cyclophosphamide and docetaxel: sequencing results from ABCSG-34 Bartsch, Rupert; Singer, Christian F.; Pfeiler, Georg; Hubalek, Michael; Stoeger, Herbert; Pichler, Angelika; Petru, Edgar; Bjelic-Radisic, Vesna; Greil, Richard; Rudas, Margaretha; Muy-Kheng, Tea Maria; Wette, Viktor; Petzer, Andreas L.; Sevelda, Paul; Egle, Daniel; Dubsky, Peter C.; Filipits, Martin; Fitzal, Florian; Exner, Ruth; Jakesz, Raimund; Balic, Marija; Tinchon, Christoph; Bago-Horvath, Zsuzsanna; Frantal, Sophie; Gnant, Michael 分享 收藏
The EndoPredict score predicts response to neoadjuvant chemotherapy and neoendocrine therapy in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients from the ABCSG-34 trial EndoPredict评分可预测ABCSG-34试验中激素受体阳性,人表皮生长因子受体2阴性乳腺癌患者对新辅助化疗和新内分泌治疗的反应 Dubsky, Peter C.; Singer, Christian F.; Egle, Daniel; Wette, Viktor; Petru, Edgar; Balic, Marija; Pichler, Angelika; Greil, Richard; Petzer, Andreas L.; Bago-Horvath, Zsuzsanna; Fesl, Christian; Meek, Stephanie M.; Kronenwett, Ralf; Rudas, Margaretha; Gnant, Michael; Filipits, Martin 分享 收藏
Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34) Singer, Christian F.; Pfeiler, Georg; Hubalek, Michael; Bartsch, Rupert; Stoeger, Herbert; Pichler, Angelika; Petru, Edgar; Bjelic-Radisic, Vesna; Greil, Richard; Rudas, Margaretha; Tea, Muy-Kheng Maria; Wette, Viktor; Petzer, Andreas L.; Sevelda, Paul; Egle, Daniel; Dubsky, Peter C.; Filipits, Martin; Fitzal, Florian; Exner, Ruth; Jakesz, Raimund; Balic, Marija; Tinchon, Christoph; Bago-Horvath, Zsuzsanna; Frantal, Sophie; Gnant, Michael 分享 收藏
REACHAUT: Real-world study of first-line (1L) ribociclib (RIB) plus endocrine therapy (ET) in HR+, HER2-metastatic breast cancer (MBC) Singer, C. F.; Egle, D.; Greil, R.; Oehler, L.; Petru, E.; Suppan, C.; Marhold, M.; Pfeiler, G.; Brunner, C.; Tinchon, C.; Halper, S.; Galid, A.; Pluschnig, U.; Haslbauer, F.; Hubalek, M.; Redl, A.; Flatschacher, J.; Hennebelle, M.; Mraz, B.; Bartsch, R. 分享 收藏
Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection (vol 10, 4666, 2019) Ulz, Peter; Perakis, Samantha; Zhou, Qing; Moser, Tina; Belic, Jelena; Lazzeri, Isaac; Woelfler, Albert; Zebisch, Armin; Gerger, Armin; Pristauz, Gunda; Petru, Edgar; White, Brandon; Roberts, Charles E. S.; John, John St.; Schimek, Michael G.; Geigl, Jochen B.; Bauernhofer, Thomas; Sill, Heinz; Bock, Christoph; Heitzer, Ellen; Speicher, Michael R. 分享 收藏
Efficacy and safety of everolimus plus exemestane in patients with HR+, HER2-advanced breast cancer progressing on/after prior endocrine therapy in routine clinical practice: Primary results from the non-interventional study, STEPAUT Steger, Guenther G.; Egle, Daniel; Bartsch, Rupert; Pfeiler, Georg; Petru, Edgar; Greil, Richard; Helfgott, Ruth; Marth, Christian; Oehler, Leopold; Hubalek, Michael; Lang, Alois; Tinchon, Christoph; Haslbauer, Ferdinand; Redl, Andreas; Hock, Karin; Hennebelle, Mathias; Mraz, Bernhard; Gnant, Michael 分享 收藏
分享 收藏